Skip to main content
Log in

Phase-III-Studie beim lokalen oder lokal fortgeschrittenen Prostatakarzinom

Randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie zu Apalutamid in Patienten mit lokalem Hoch-Risiko-Prostatakarzinom oder lokal fortgeschrittenem Prostatakarzinom, die eine primäre Radiotherapie erhalten (ATLAS) – Studie AP 90/15 der AUO

Phase III study for local or locally advanced prostate cancer

Randomized, double-blind, placebo-controlled phase 3 study of apalutamide in patients with local high-risk prostate cancer or locally advanced prostate cancer receiving primary radiotherapy (ATLAS) – study AP 90/15 of the AUO

  • AUO
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Rexer.

Ethics declarations

Interessenkonflikt

H. Rexer und M. Graefen geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rexer, H., Graefen, M. Phase-III-Studie beim lokalen oder lokal fortgeschrittenen Prostatakarzinom. Urologe 56, 243–244 (2017). https://doi.org/10.1007/s00120-017-0329-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-017-0329-0

Navigation